Application of Platelet-Rich Plasma as a Stem Cell Treatment - anAttempt to Clarify a Common Public Misconception

    May 2023 in “ Current Molecular Medicine
    Ismail M. Fareez, Fong Fong Liew, Darius Widera, Naiyareen Mayeen, Jannatul Mawya, Noor Hayaty Abu Kasim, Nazmul Haque, Nazmul Haque
    TLDR PRP is not a stem cell treatment and should not be marketed as such.
    The document clarifies a common misconception that equates platelet-rich plasma (PRP) with stem cell-based therapies. While PRP is popular for its regenerative potential in treating musculoskeletal and dermatological disorders, it only provides growth factors and cannot replace lost cells, unlike stem cell therapies. The document emphasizes that PRP should not be marketed as a stem cell treatment and calls for regulatory oversight to prevent misleading claims by commercial entities offering regenerative therapies.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Research

    1 / 1 results